BSRBR: Toxicity from Biological Therapy
Principal Investigator: Dawn Collier, Research Nurse Sponsor: University of Manchester The BSRBR-RA study tracks the progress of people with rheumatoid arthritis (RA) who have been prescribed biologic (including biosimilar) and other targeted therapies in the UK to monitor the long-term safety of these drugs. |